Patent · US Active

Fused ring compounds

US12084429B2 · kind B2 · utility

0Cited by
12References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2021
Grant dateSep 10, 2024
Priority date
Expiry dateMar 20, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention pertains to fused ring compounds of Formula (I), as further detailed herein, which are used for the inhibition of Ras proteins, as well as compositions comprising these compounds and methods of treatment by their administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.